Use of pharmaceutical ingredients, including anthrax derivatives and serotonin reuptake inhibitors, to prepare drugs for animation disorders

摘要

1. A procedure for the preparation of a disorder drug using a pharmaceutical component containing at least one anthrax derivative and at least one inhibitor inhibiting serotonin reabsorption. Claim 5: procedure for claim 4, characterized by aripiprazol's metabolites being dehidrorariprazol, dm-1458, dm-1451, dm-1452, dm-1454 or DPP. 6. Claim 6: the procedure for the processing of any one to five claims, characterized by the fact that at least the only inhibitor inhibiting the reabsorption of serotonin is selected from the CFC group,duloxetina venlafaxina milnacipran citalopram fluvoxamina paroxetina sertralina escitalopram y sales de los mismos Reivindicaci n 7 Procedimiento de acuerdo con la reivindicaci n 6 caracterizado porque el al menos nico inhibidor de la reabsorci n de serotonina es citalopram Reivindicaci n 12 Procedimiento de acuerdo a cualquiera de las reivindicaciones Parkinson's disease includes depression, Alzheimer's disease, mental disorder related to cerebral vessels, mental disorder after head injury, etc.